Little is known about the regulation of development and growth of
GTD. Here we describe the first time detection of hGH-V in the patient's
blood in GTD and the establishment of an immunohistochemistry setup
for hGH-V in GTD.We further present the time course of hGH-V in
GTDfor selected clinical cases and discuss its possible use as a biomarker
in the future clinical routine.